Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease.
about
PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementiaIntracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD miceCerebral metabolism, anatomy, and cognition in monozygotic twins discordant for dementia of the Alzheimer type.Dominantly inherited Alzheimer's disease: cerebral glucose metabolismDecline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.Focal cerebral hypoperfusion and selective cognitive deficit in dementia of the Alzheimer typeCombining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging InitiativeDrug development for neurodegenerative diseases: role of PET.Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine.Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia.Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairmentA survey of FDG- and amyloid-PET imaging in dementia and GRADE analysisUsing biomarkers to improve detection of Alzheimer's disease.Understanding dementia prevalence among centenarians.Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.Regional correction of positron emission tomography data for the effects of cerebral atrophy.The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.Behavioral and omics analyses study on potential involvement of dipeptide balenine through supplementation in diet of senescence-accelerated mouse prone 8.Quantitative evaluation of Alzheimer's disease.Imaging dementia with SPECT.The concept of FDG-PET endophenotype in Alzheimer's disease.Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.Brain metabolism in health, aging, and neurodegeneration.Cerebral blood flow and metabolism in normal human aging, pathological aging, and senile dementia.Glucose metabolism and rate constants in Alzheimer's disease examined with dynamic positron emission tomography scan.Brain functional network in Alzheimer's disease: diagnostic markers for diagnosis and monitoring.Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index.Magnetic resonance imaging evaluation of the effects of ageing on grey-white ratio in the human brain.Topographical analysis of glucose metabolism, as measured with positron emission tomography, in dementia of the Alzheimer type: use of linear histograms.Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease.Changes in brain monoaminergic neurotransmitter concentrations in rat after intracerebroventricular injection of streptozotocin.Human brain glucose utilization and cognitive function in relation to age.Decreases in regional cerebral blood flow with normal aging.Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer's disease.Metabolic brain networks in aging and preclinical Alzheimer's disease.Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy.Mitochondrial Chaperones in the Brain: Safeguarding Brain Health and Metabolism?
P2860
Q24604133-ADC1C7B4-E8A8-4E0F-8D92-6280294E831FQ30573779-48C5B49A-E699-4223-9CFA-E0B4366067C2Q33627955-C25C618E-F584-4729-9360-C37834A5A12FQ33628634-BC9CFC88-00E0-4B09-90F4-FCC265BFBAE3Q33628645-77501CBC-4355-456A-8DCF-15209BCC87B6Q33629964-D1181DDA-D963-4B35-93F9-94765AB35C10Q33651118-E40D1F66-F5F9-42DD-992B-154FBDB6ADDAQ33798435-C2B097DA-736C-4FE2-9642-C1A11FEAEED1Q33841672-DB662E0A-7BC3-4C9A-8B54-E2E862CBACABQ33917702-8480E8AB-5796-4058-A4F6-6A2F3163783EQ34879008-881A9183-2FA9-4C8F-9094-F400A4104AF9Q35117821-4AF7580B-33CA-482C-ABC2-0D298BA9F7CBQ35120662-8F691818-306D-4BEE-9F5B-F23FB6BB2BF3Q35158547-61419FCF-DDCF-468C-9740-3999ED4CFCE1Q35533115-7873DEEB-6F44-4A21-8FB6-388FAD5F5121Q35845305-CCD2D1CC-C52C-45EC-9D8F-CD1E23DA6004Q36098880-1E84CEDA-AEB1-4DAC-8E80-C18EA9168783Q36443786-0AB2181A-89E2-48F8-843E-EEA361FE9B70Q37108142-B281B0D2-588E-46E4-9951-9313914F3A85Q37270852-B5D3D6FA-08DF-4F89-B440-E4C4CA064070Q37596431-5C02440D-B535-48DC-B793-2941B6DD253FQ37722803-4AEBC219-91B3-4C8E-8B63-F7B0DF2045FCQ37883153-487508CF-1C75-4EF2-8A32-8DE308D7E6F6Q38773531-92B918DD-101A-402D-BA8B-77BB0793F1C5Q39259780-9B92C097-9090-406E-B0E9-36B87F92DCB6Q39856970-EE209882-7843-45BA-846C-BBC7B62202D3Q42123032-64B715C1-64CD-4E9E-A790-1B9612E9F873Q42124171-F23878B6-C813-4FC2-B2DC-76C22EE76FE3Q46502975-1767F055-772A-4075-8104-81E42F33F622Q48116199-73ECC7B4-A0E2-4A28-8D2A-F67F6F1DD2E6Q48213415-83C9F46F-52E0-4A51-B911-B8159EDADD0EQ48483328-CE755C7D-6A72-4950-BB05-C9A13A346907Q48591271-04F8AB74-1410-4D8B-AE71-D7AB79A2DCF9Q48597174-28ECD093-AC8A-459F-BDB7-C8E763E5DD5FQ48692518-8E7E2757-55E6-4938-BE0E-68760704CCADQ48799327-ECB607D4-2026-409D-B2CF-C9C902669C04Q50531249-1A9A956D-6580-4D5A-8A29-703BAAAE9D9EQ52062294-E8F6405C-855F-4A34-B362-318DD376B500Q55283805-FB5E1724-7A60-4530-BBBF-A37B493154AD
P2860
Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh-hant
name
Computed tomography and positr ...... aging and Alzheimer's disease.
@en
Computed tomography and positr ...... aging and Alzheimer's disease.
@nl
type
label
Computed tomography and positr ...... aging and Alzheimer's disease.
@en
Computed tomography and positr ...... aging and Alzheimer's disease.
@nl
prefLabel
Computed tomography and positr ...... aging and Alzheimer's disease.
@en
Computed tomography and positr ...... aging and Alzheimer's disease.
@nl
P2093
P2860
P50
P356
P1476
Computed tomography and positr ...... aging and Alzheimer's disease
@en
P2093
Christman DR
Kricheff II
P2860
P304
P356
10.1038/JCBFM.1983.57
P577
1983-09-01T00:00:00Z